Pseudomonas aeruginosa and periodontal pathogens in the oral cavity and lungs of cystic fibrosis patients: A case-control study

Journal of Clinical Microbiology

Volumn 53, Issue 6, 2015, Pages 1898-1907

  Caldas, Rocio Rivas ^a   Le Gall, Florence ^a,c   Revert, Krista ^b   Rault, Gilles ^b   Virmaux, Michèle ^a   Gouriou, Stephanie ^a   Héry Arnaud, Geneviève ^a   Barbier, Georges ^a   Boisramé, Sylvie ^a  

^a UNIVERSITÉ DE BREST   (France)

^b Cystic Fibrosis Reference Center   (France)

^c Hopital Laennec   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; FEMALE; HOMOZYGOSITY; HUMAN; MALE; MICROBIAL DIVERSITY; MOLECULAR MODEL; MOUTH CAVITY; MUTATIONAL ANALYSIS; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SCHOOL CHILD; SPUTUM ANALYSIS; TOOTH FLORA; YOUNG ADULT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUTH; SPUTUM; TOOTH PLAQUE;

PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DENTAL PLAQUE; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MOUTH; PSEUDOMONAS AERUGINOSA; SPUTUM; YOUNG ADULT;

EID: 84929359373     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00368-15     Document Type: Article

References (48)

1. Scotet V, Gillet D, Duguépéroux I, Audrézet MP, Bellis G, Garnier B, Roussey M, Rault G, Parent P, De Braekeleer M, Férec C, Réseau Mucoviscidose Bretagne et Pays de Loire. 2002. Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960. Hum Genet 111:247-254. http://dx.doi .org/10.1007/s00439-002-0788-1.
2. Scotet V, Dugueperoux I, Saliou P, Rault G, Roussey M, Audrezet MP, Ferec C. 2012. Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France. Orphanet J Rare Dis 7:14. http://dx.doi.org/10.1186/1750-1172-7-14.
3. Lee TW, Matthews DA, Blair GE. 2005. Novel molecular approaches to cystic fibrosis gene therapy. Biochem J 387:1-15. http://dx.doi.org/10.1042/BJ20041923.
4. Taylor CJ, McGaw J, Howden R, Duerden BI, Baxter PS. 1990. Bacterial reservoirs in cystic fibrosis. Arch Dis Child 65:175-177. http://dx.doi.org/10.1136/adc.65.2.175.
5. Muhlebach MS, MacDonald SL, Button B, Hubbard JJ, Turner ML, Boucher RC, Kilpatrick DC. 2006. Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent. Clin Exp Immunol 145:302-307. http://dx.doi.org/10.1111/j.1365-2249 .2006.03151.x.
6. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis.AmJ Respir Crit Care Med 168:918-951. http://dx.doi.org/10.1164/rccm.200304-505SO.
7. Rosenfeld M, Emerson J, McNamara S, Thompson V, Ramsey BW, Morgan W, Gibson RL, EPIC Study Group. 2012. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros 11:446-453. http://dx.doi.org/10.1016/j.jcf.2012.04 .003.
8. Saiman L, Siegel J, Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. 2003. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 31(Suppl):S1-S62. http://dx.doi.org/10.1067/mic.2003.78.
9. Drenkard E, Ausubel FM. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743. http://dx.doi.org/10.1038/416740a.
10. Mayer-Hamblett N, Rosenfeld M, Gibson RL, Ramsey BW, Kulasekara HD, Retsch-Bogart GZ, Morgan W, Wolter DJ, Pope CE, Houston LS, Kulasekara BR, Khan U, Burns JL, Miller SI, Hoffman LR. 2014. Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes. Am J Respir Crit Care Med 190:289-297. http://dx.doi.org/10.1164/rccm.201404-0681OC.
11. Sadikot RT, Blackwell TS, Christman JW, Prince AS. 2005. Pathogenhost interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171:1209-1223. http://dx.doi.org/10.1164/rccm.200408 -1044SO.
12. Cantón R, Fernández Olmos A, de la Pedrosa EG, del Campo R, Antonia Meseguer M. 2011. Chronic bronchial infection: the problem of Pseudomonas aeruginosa. Arch Bronconeumol 47(Suppl 6):8 -13. (In Spanish.) http://dx.doi.org/10.1016/S0300-2896(11)70029-1.
13. Drenkard E. 2003. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 5:1213-1219. http://dx.doi.org/10.1016/j.micinf .2003.08.009.
14. Digoy GP, Dunn JD, Stoner JA, Christie A, Jones DT. 2012. Bacteriology of the paranasal sinuses in pediatric cystic fibrosis patients. Int J Pediatr Otorhinolaryngol 76:934-938. http://dx.doi.org/10.1016/j.ijporl.2012 .02.043.
15. Muhlebach MS, Miller MB, Moore C, Wedd JP, Drake AF, Leigh MW. 2006. Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatr Pulmonol 41:445-451. http://dx.doi.org/10.1002/ppul.20396.
16. Mainz JG, Hentschel J, Schien C, Cramer N, Pfister W, Beck JF, Tummler B. 2012. Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation. J Cyst Fibros 11:158-161. http://dx.doi.org/10.1016/j.jcf.2011.10.009.
17. Amaral SM, Cortês Ade Q, Pires FR. 2009. Nosocomial pneumonia: importance of the oral environment. J Bras Pneumol 35:1116-1124 (In Portuguese.) http://dx.doi.org/10.1590/S1806-37132009001100010.
18. Raghavendran K, Mylotte JM, Scannapieco FA. 2007. Nursing homeassociated pneumonia, hospital-acquired pneumonia and ventilatorassociated pneumonia: the contribution of dental biofilms and periodontal inflammation. Periodontol 2000 44:164-177. http://dx.doi.org/10.1111/j.1600-0757.2006.00206.x.
19. Heo SM, Haase EM, Lesse AJ, Gill SR, Scannapieco FA. 2008. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin Infect Dis 47:1562-1570. http://dx.doi.org/10.1086/593193.
20. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG. 2010. The human oral microbiome. J Bacteriol 192:5002-5017. http://dx.doi.org/10.1128/JB.00542-10.
21. Fourrier F, Duvivier B, Boutigny H, Roussel-Delvallez M, Chopin C. 1998. Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients. Crit Care Med 26:301-308. http://dx.doi.org/10.1097/00003246-199802000-00032.
22. Scannapieco FA, Yu J, Raghavendran K, Vacanti A, Owens SI, Wood K, Mylotte JM. 2009. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care 13: R117. http://dx.doi.org/10.1186/cc7967.
23. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109:317-325. http://dx.doi.org/10.1172/JCI13870.
24. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, Ciofu O, Mandsberg L, Kharazmi A, Doring G, Givskov M, Hoiby N, Jensen PO. 2010. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65:57-62. http://dx.doi.org/10.1136/thx.2009.114512.
25. Kolpen M, Kuhl M, Bjarnsholt T, Moser C, Hansen CR, Liengaard L, Kharazmi A, Pressler T, Hoiby N, Jensen PO. 2014. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLoS One 9: e84353. http://dx.doi.org/10.1371/journal.pone.0084353.
26. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177:995-1001. http://dx.doi.org/10.1164/rccm.200708-1151OC.
27. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. 2003. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2:29-34. http://dx.doi.org/10.1016/S1569-1993(02)00141-8.
28. Courcol R, Herrmann J, Laudat P, Pangon B, Peigue-Lafeuille H (ed). 2010. Référentiel en microbiologie médicale (Rémic), 2nd ed, p 99-104. Société Française de Microbiologie, Paris, France.
29. Le Gall F, Le Berre R, Rosec S, Hardy J, Gouriou S, Boisrame-Gastrin S, Vallet S, Rault G, Payan C, Hery-Arnaud G. 2013. Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis.BMCMicrobiol 13:143. http://dx.doi.org/10.1186/1471-2180-13-143.
30. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. 1998. Microbial complexes in subgingival plaque. J Clin Periodontol 25:134-144. http://dx.doi.org/10.1111/j.1600-051X.1998.tb02419.x.
31. Govan JR, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539-574.
32. Hogardt M, Heesemann J. 2013. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr Top Microbiol Immunol 358:91-118. http://dx.doi.org/10.1007/82-2011-199.
33. Eichner A, Gunther N, Arnold M, Schobert M, Heesemann J, Hogardt M. 2014. Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment. Int J Med Microbiol 304: 1050-1061. http://dx.doi.org/10.1016/j.ijmm.2014.07.014.
34. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS. 2004. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 48:2659-2664. http://dx.doi.org/10.1128/AAC.48.7.2659-2664.2004.
35. Warren AE, Boulianne-Larsen CM, Chandler CB, Chiotti K, Kroll E, Miller SR, Taddei F, Sermet-Gaudelus I, Ferroni A, McInnerney K, Franklin MJ, Rosenzweig F. 2011. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections. Infect Immun 79:4802-4818. http://dx.doi.org/10.1128/IAI.05282-11.
36. Logan C, Habington A, Lennon G, Grogan J, Byrne M, O'Leary J, O'Sullivan N. 2012. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland. J Med Microbiol 61:64-70. http://dx.doi.org/10.1099/jmm.0.035642-0.
37. Cramer N, Wiehlmann L, Ciofu O, Tamm S, Hoiby N, Tummler B. 2012. Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis. PLoS One 7: e50731. http://dx.doi.org/10.1371/journal.pone.0050731.
38. Mainz JG, Naehrlich L, Schien M, Kading M, Schiller I, Mayr S, Schneider G, Wiedemann B, Wiehlmann L, Cramer N, Pfister W, Kahl BC, Beck JF, Tummler B. 2009. Concordant genotype of upper and lower airways P. aeruginosa and S. aureus isolates in cystic fibrosis. Thorax 64: 535-540. http://dx.doi.org/10.1136/thx.2008.104711.
39. Narang A, Maguire A, Nunn JH, Bush A. 2003. Oral health and related factors in cystic fibrosis and other chronic respiratory disorders. Arch Dis Child 88:702-707. http://dx.doi.org/10.1136/adc.88.8.702.
40. Kinirons MJ. 1989. Dental health of patients suffering from cystic fibrosis in Northern Ireland. Community Dent Health 6:113-120.
41. Löe H. 2000. Oral hygiene in the prevention of caries and periodontal disease. Int Dent J 50:129-139. http://dx.doi.org/10.1111/j.1875-595X .2000.tb00553.x.
42. Socransky SS, Haffajee AD. 2005. Periodontal microbial ecology. Periodontology 2000 38:135-187. http://dx.doi.org/10.1111/j.1600-0757.2005.00107.x.
43. da Silva-Boghossian CM, do Souto RM, Luiz RR, Colombo AP. 2011. Association of red complex, A. actinomycetemcomitans and non-oral bacteria with periodontal diseases. Arch Oral Biol 56:899-906. http://dx.doi.org/10.1016/j.archoralbio.2011.02.009.
44. Colombo AP, Teles RP, Torres MC, Souto R, Rosalem WJ, Mendes MC, Uzeda M. 2002. Subgingival microbiota of Brazilian subjects with untreated chronic periodontitis. J Periodontol 73:360-369. http://dx.doi.org/10.1902/jop.2002.73.4.360.
45. Blandizzi C, Malizia T, Lupetti A, Pesce D, Gabriele M, Giuca MR, Campa M, Del Tacca M, Senesi S. 1999. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol 70:960-966. http://dx.doi.org/10.1902/jop.1999 .70.9.960.
46. Kolenbrander PE, Palmer RJ, Jr, Periasamy S, Jakubovics NS. 2010. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8:471-480. http://dx.doi.org/10.1038/nrmicro2381.
47. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, Huttenhower C. 2012. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 8: e1002606. http://dx.doi.org/10.1371/journal.pcbi.1002606.
48. Charlson ES, Bittinger K, Chen J, Diamond JM, Li H, Collman RG, Bushman FD. 2012. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One 7: e42786. http://dx.doi.org/10.1371/journal.pone.0042786.